You are here

FSP Group Investor Alert: Symtomax keeps investors happy with major launch of new Oral Tabs CBD product

Cannabis cultivation business Symtomax have announced the launch of new CBD product Oral Tabs – featuring a revolutionary new method.

Find out more

New Cannabis Report Predicts Legal Sales To Reach Nearly $30 Billion By 2025

CBD Oil - Marijuana Products encompassing many aspects of daily life, including our Pets

Find out more

The global medical marijuana market is projected to expand

The global medical marijuana market is projected to expand by a compound annual growth rate (CAGR) of 22.4% through 2024, according to estimates from That's a market of more than $44 billion that's ripe for the picking for companies that are ready for the challenge.

But what does it take to succeed in the medical marijuana industry? And which stocks are most likely to profit from the industry's growth and are smart picks for investors? Here's what you need to know about investing in medical marijuana.

Find out more

Emerging Markets Report: At the Intersection of Cannabis and Commerce

ORLANDO, Fla., Feb. 05, 2020 (GLOBE NEWSWIRE) -- It has been a mercurial run for cannabis companies over the past year or so. Many have seen their market shares curbed and cropped among an industry-wide correction. The markets have not been kind.

But in stark juxtaposition is the cannabis industry itself which, while shaking out weaker hands and lesser ideas, is rapidly expanding as legal walls fall to the wayside and more crops bloom. In fact, a recent Forbes article cites a report that predicts legal cannabis sales will grow to nearly $30 billion by 2025.

Find out more